daacro at the 42nd DGPharMed Annual Congress

The 42nd Annual Congress of the German Society for Pharmaceutical Medicine (DGPharMed) featured a diverse program covering current topics in clinical research and brought together leading experts from across the field.
Dr. Juliane Hellhammer actively contributed to the congress: she chaired the session “Biosimilar Development: New FDA and EMA Regulation Are a Paradigm Shift After 20 Years of Biosimilars”, participated in the round table “Women in Leadership”, and delivered a scientific presentation on “Sleep Under Observation: Opportunities and Side Effects of Modern Wearables”.

This year’s congress featured a diverse and highly relevant program, highlighting key developments and challenges in clinical research – ranging from regulatory changes to innovative technologies. The intensive professional exchange and interdisciplinary perspectives made the event a valuable platform for knowledge sharing and networking.
We are pleased to have been part of this important industry event and to contribute to the professional exchange.